Liverpool Science Park
  • About
    • Our Customers
    • Our Stakeholders
  • Spaces
    • Office Space
    • Lab Space
    • Co-working Space
    • Virtual Office
    • Benefits
  • News & Events
  • Contact
  • Portal
  • Search
  • Menu

LSP-based MedTech firm signs first major distribution agreement

You are here: Home / News / LSP-based MedTech firm signs first major distribution agreement

North West MedTech firm signs first major distribution agreement

Enteral Access Technologies (E.A.T.), a medical device company headquartered in Liverpool, has signed its first major distribution agreement with Medicina, a large trust-wide distributor of medical devices for enteral feeding.

Under the terms of the agreement, Medicina will market and sell DoubleCHEK™ to hospitals and end users throughout the UK and Ireland.  The distribution agreement may be expanded to cover additional products and territories in the future.

DoubleCHEK™ is a patented device that uses CO2 and pH indicators to prevent the misplacement of feeding tubes into the lungs, a ‘never event’ in the NHS. Using its proprietary valve and pump system, it collects small samples of aspirate to the indicator tests, ‘double checking’ correct placement and reducing the potential for harm. The distributor announcement follows a successful funding round in which the company secured £750,000 to manufacture the DoubleCHEK™ device in the UK.

George Gallagher, CEO, Enteral Access Technologies, said:

“Medicina is a great partner for E.A.T. They have the scale, infrastructure, reputation, and complementary product portfolio to power DoubleCHEK™ to a market share leading position. We are pleased that Medicina recognizes the innovation and patient safety elements that DoubleCHEK™ offers to clinicians in the fight against Never Events”.

NHS Supply Chain purchases a million nasogastric (NG) feeding tubes annually, which take skill and experience to insert correctly. Feeding tube misplacement results in significant patient harm and can be life threatening, so the partnership presents an opportunity to significantly improve patient safety when it comes to NG placement.

Appraising the decision to partner with E.A.T, Medicina Managing Director Tracey Macdonald said:

“Enteral feeding is a critical need for many patients and offering DoubleCHEK™ will provide an additional layer of safety when nasogastric tubes are used to deliver enteral nutrition. We expect DoubleCHEK™ to do very well as there is a clear need for this product within the healthcare market.”

Pages

  • About
  • Benefits
  • Co-working Space
  • Contact
  • Cookie Policy
  • Home
  • Home – New Brand
  • Lab Space
  • News & Events
  • Office Space
  • Our Customers
  • Our Stakeholders
  • Spaces
  • Virtual Office

Categories

  • Events
  • News
  • Uncategorised

Archive

  • June 2022
  • May 2022
  • April 2022
  • March 2022
  • December 2021
  • October 2021
  • September 2021
  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • September 2019
  • February 2019

Locations

Liverpool Science Park
Innovation Centre One
131 Mount Pleasant
Liverpool
L3 5TF

Liverpool Science Park
Innovation Centre Two
146 Brownlow Hill
Liverpool
L3 5RF

Follow

Twitter

LinkedIn

Facebook

Instagram

 

Legal

Privacy & Data Policy

Cookie Policy

Stay Connected

If you would like details of our latest news, events and opportunities sent directly to your inbox, sign-up to receive our Sciontec e-newsletters.


    New Entrance Scheme at LSP Revealed Growth Platform Hosts Webinar to Help Businesses Bounce Back
    Scroll to top